Aigen Investment Management »

Cerevel Therapeutics Hldng I shares owned by Aigen Investment Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Aigen Investment Management from 13F filings

Historical chart of Aigen Investment Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Aigen Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Aigen Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $348k 8.2k 42.40

More positions owned by Aigen Investment Management

Exxon Mobil Corporation (XOM)
NVIDIA Corporation (NVDA)
Tyson Foods Cl A (TSN)
Whirlpool Corporation (WHR)
Apa Corporation (APA)
Skechers U S A Cl A (SKX)
Alnylam Pharmaceuticals (ALNY)
MercadoLibre (MELI)
Archer Daniels Midland Company (ADM)
Visa Com Cl A (V)
On Hldg Namen Akt A (ONON)
McDonald's Corporation (MCD)
At&t (T)
Draftkings Com Cl A (DKNG)
Best Buy (BBY)

View all positions for Aigen Investment Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I